Leading generics pharmaceutical company
The second wave of Covid-19 could be worse, and there’s potential for a double whammy #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
It’s likely you can, at least for some period of time. That is opening new opportunities for testing and treatment. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
The WHO said there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. The World Health Organization issued a warning Friday about coronavirus testing, saying there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Medical News, Press Release
ProPublica’s health reporter Caroline Chen explains what the conversation around asymptomatic coronavirus carriers is missing, and what we need to understand if we’re going to beat this nefarious virus together.
The FDA has approved an abbreviated new drug application for hydroxychloroquine sulfate tablets to address ongoing shortages of the drug sparked by its still unproven potential as a COVID-19 treatment. The application, submitted by Accord Healthcare, was approved on April 7. The approved indications are uncomplicated malaria due to Plasmodium falciparum, P. malariae, P. ovale, and P. vivax; chronic discoid lupus erythematosus and systemic lupus erythematosus in adults; and acute and chronic rheumatoid arthritis in adults.
The latest on the potential Covid-19 treatment under research. A daily Covid-19 update from {Taj Pharmaceuticals Limited} Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
Some politicians and doctors are sparring over whether to use Hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it now. The drug Hydroxychloroquine can help tame an overactive immune system. It’s been used since the 1940s to prevent and treat malaria, and to treat rheumatoid arthritis and lupus. It’s sold in generic form and under the brand name Plaquenil in the United States. Doctors also can prescribe it off label for other purposes, as many are doing now for COVID-19.
The first COVID-19 vaccine in China is expected to be ready for clinical trials by the end of April, according to Xu Nanping, China’s vice-minister of science and technology. Inovio Pharmaceuticals plans to begin clinical trials on a coronavirus vaccine in April this year.
Clinical trials for drugs targeting IL-6 to slow the immune system are underway in the fight against Covid-19
A woman takes a swab test for the virus. Credit: ITV News Central The government has been under fire for several days now about the rate of testing for Coronavirus, especially among front-line heath workers.
Clinical trials will test if antibodies against the coronavirus prevent infection, aid survival. Can plasma from recovered COVID-19 patients treat the sick?
Dear Colleagues/ Agents / Distributors, The growing outbreak of COVID-19 has affected each one of us in multiple ways, our families, friends, businesses and way of life. This fast-changing situation has forced us to re-evaluate how we operate. At Taj Pharmaceuticals, we are working on using this challenge as an opportunity to make our company […]
Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.
We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Taj Pharmaceuticals Limited company information | Taj Pharmaceuticals Key Executives | Taj Pharmaceuticals overview | Taj Pharmaceuticals
As the novel coronavirus (COVID-19) situation continues to evolve and business impacts are becoming more far reaching across every sector, I wanted to share what we are doing at Taj Pharmaceuticals to ensure the continuity in our support of you and the animals in your care. Read more
Taj Pharmaceuticals organizes response to outbreaks of infectious diseases worldwide through the company’s Center for Transboundary and Emerging Diseases. Taj Pharmaceuticals scientists mobilize resources from across the company and work closely with leaders from government, health organizations, and the veterinary and livestock agricultural communities to identify infectious disease threats early and develop solutions, including vaccines and diagnostic tests, to help rapidly control them.
Coronavirus: Everything you need to know: China coronavirus: All you need to know – A new virus has killed 81 people in China and infected almost 3,000 people, with cases confirmed in several countries.
In Wuhan, China, where the novel coronavirus has killed at least 106 people and sickened 4,515 more, wearing face masks is mandatory. Half a world way in the US, major retailers are selling out of basic surgical masks amid panic from consumers.(So far, there have been five confirmed cases of coronavirus here.)Surgical masks are a […]
The analytical stages when a suspected issue is found in a product Contamination is arguably one of the greatest concerns in pharmaceutical manufacture, potentially compromising the final product. But when a problem is found, quick action by a Qualified Person (QP) and further analysis can make sure any problem is limited and patients are protected. […]
Mental health: Expert tips on tackling anxiety and depression Why don’t men ask for help when they feel depressed? Research by charity Mental Health Foundation showed men were less likely than women to seek help when feeling depressed. They are also more likely to seek help in A&E when their depression is at an acute […]
The first generic versions of the powerful blood thinner Eliquis (apixaban) were approved by the U.S. Food and Drug Administration on Monday. “Today’s approvals of the first generics of apixaban are an example of how the FDA’s generic drug program improves access to lower-cost, safe and high-quality medicines,” Dr. Janet Woodcock, director of the FDA’s […]
The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients. “Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA,” said Janet Woodcock, M.D., director of […]
More drugs are in short supply for longer periods of time due to a fundamentally flawed pharmaceutical supply chain, according to a new report. The number of ongoing drug shortages has increased from 2017 to 2018 after declining from a peak in 2011. Shortages have also been lasting longer, in some cases more than eight […]
Consumer Reports examines why prescription drug prices are rising so sharply—and how to lower your drug costs As consumers, we know the difference between products we want and products we need. For luxury or convenience items, it’s easy enough to hold off on a purchase if our budget demands it—but for the things we can’t […]
